Treatment of benign prostatic hyperplasia through transurethral needle ablation (TUNA™) -: Review of the literature and six years of clinical experience

被引：20
|
作者：
Braun, M
Mathers, M
Bondarenko, B
Engelmann, U
机构：
[1] Univ Cologne, Dept Urol, DE-50924 Cologne, Germany
[2] Dept Urol, Remscheid, Germany
来源：
UROLOGIA INTERNATIONALIS | 2004年 / 72卷 / 01期
关键词：
transurethral needle ablation of the prostate; BPH; long-term results;
D O I：
10.1159/000075270
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
Following FDA clearance and the establishment of Medicare coverage, transurethral needle ablation ( TUNA) has become an established and widely-adopted treatment method for BPH in the USA. Germany is lagging behind at present, though a change can also be recognized there. The lack of long-term data has often been criticized. This review presents an overview of clinical outcomes of TUNA, long-term results and patient selection criteria. Copyright (C) 2004 S. Karger AG, Basel.
引用
收藏
页码：32 / 39
页数：8
相关论文
共 50 条
  • [31] Transurethral needle ablation versus transurethral resection of the prostate for the treatment of symptomatic benign prostatic hyperplasia: 5-year results of a prospective, randomized, multicenter clinical trial
    Hill, B
    Belville, W
    Bruskewitz, R
    Issa, M
    Perez-Marrero, R
    Roehrborn, C
    Terris, M
    Naslund, M
    JOURNAL OF UROLOGY, 2004, 171 (06): : 2336 - 2340
  • [32] Possible mechanisms of action of transurethral needle ablation of the prostate on benign prostatic hyperplasia symptoms: A neurohistochemical study
    Mostafid, H
    Harrison, N
    JOURNAL OF UROLOGY, 1998, 159 (01): : 209 - 210
  • [33] Transurethral Ultrasound Ablation for Treatment of Localized Prostate Cancer and Benign Prostatic Hyperplasia (BPH)
    Engelage, Lucas
    Muschter, Rolf
    JOURNAL OF ENDOUROLOGY, 2025, 39 : S23 - S26
  • [34] Possible mechanisms of action of transurethral needle ablation of the prostate on benign prostatic hyperplasia symptoms: A neurohistochemical study
    Zlotta, AR
    Raviv, G
    Peny, MO
    Noel, JC
    Haot, J
    Schulman, CC
    JOURNAL OF UROLOGY, 1997, 157 (03): : 894 - 899
  • [35] A cost comparison of medical management and transurethral needle ablation for treatment of benign prostatic hyperplasia during a 5-year period
    Naslund, MJ
    Carlson, AM
    Williams, MJ
    JOURNAL OF UROLOGY, 2005, 173 (06): : 2090 - 2093
  • [36] Transurethral needle ablation for treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia:: Outcome after 1 year
    Dæhlin, L
    Gustavsen, A
    Nilsen, AH
    Mohn, J
    JOURNAL OF ENDOUROLOGY, 2002, 16 (02) : 111 - 115
  • [37] Transurethral microwave thermotherapy for benign prostatic hyperplasia: Clinical outcome after 4 years
    Hallin, A
    Berlin, T
    JOURNAL OF UROLOGY, 1998, 159 (02): : 459 - 464
  • [38] Is transurethral needle ablation of prostate out of fashion? Outcomes of single session office-based transurethral needle ablation of prostate in patients with symptomatic benign prostatic hyperplasia
    Law, Yu Xi Terence
    Chen, Wei Jing Kelven
    Shen, Liang
    Chua, Wei Tin
    INVESTIGATIVE AND CLINICAL UROLOGY, 2019, 60 (05) : 351 - 358
  • [39] Transurethral ultrasound ablation (TULSA) for benign prostatic hyperplasia: Three-month clinical outcomes
    Viitala, A.
    Anttinen, M.
    Doerwald, P.
    Makela, P.
    Sainio, T.
    Virtanen, I
    Taimen, P.
    Sequeiros, Blanco R.
    Bostrom, P. J.
    EUROPEAN UROLOGY, 2022, 81 : S1085 - S1085
  • [40] Transurethral needle ablation for benign prostatic hyperplasia: 12-month results of a prospective, multicenter US study
    Roehrborn, CG
    Issa, MM
    Bruskewitz, RC
    Naslund, MJ
    Oesterling, JE
    Perez-Marrero, R
    Shumaker, BP
    Narayan, P
    UROLOGY, 1998, 51 (03) : 415 - 421
12345